Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines

Clinical trial NCT04875676 · COMPLETED

Trial details

NCT number: NCT04875676
Sponsor: Vaxart
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Norovirus Infections

Start date: 2021-04-30
Primary completion: 2021-10-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.